OnKure Financial Statements From 2010 to 2026

OKUR Stock   2.32  0.08  3.33%   
OnKure Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing OnKure Therapeutics' valuation are provided below:
Market Capitalization
32.5 M
Earnings Share
(4.68)
There are over one hundred twelve available trending fundamental ratios for OnKure Therapeutics, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to check out OnKure Therapeutics' recent fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction. As of 02/05/2026, Market Cap is likely to grow to about 237.2 M, while Enterprise Value is likely to drop slightly above 5.5 M.
Check OnKure Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OnKure Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 799.4 K, Other Operating Expenses of 39.7 M or Research Development of 32.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.04. OnKure financial statements analysis is a perfect complement when working with OnKure Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with OnKure Stock
Check out the analysis of OnKure Therapeutics Correlation against competitors.
To learn how to invest in OnKure Stock, please use our How to Invest in OnKure Therapeutics guide.

OnKure Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets82.7 M132.1 M67.2 M
Slightly volatile
Short and Long Term Debt Total927.7 K976.5 K60.3 M
Slightly volatile
Other Current Liabilities5.4 M8.1 M4.9 M
Slightly volatile
Total Current Liabilities7.5 M12.1 M5.9 M
Slightly volatile
Property Plant And Equipment Net1.3 M2.1 M595 K
Slightly volatile
Cash72.7 M127.4 M62.7 M
Slightly volatile
Non Current Assets Total1.5 M2.2 M727.4 K
Slightly volatile
Non Currrent Assets Other112.2 K98.1 K128.3 K
Very volatile
Cash And Short Term Investments56.6 M99.7 M61.5 M
Slightly volatile
Common Stock Shares Outstanding9.8 M15.3 M5.6 M
Slightly volatile
Liabilities And Stockholders Equity82.7 M132.1 M67.2 M
Slightly volatile
Non Current Liabilities Total469.4 K494.1 K71.6 M
Slightly volatile
Other Current Assets2.5 MMM
Slightly volatile
Other Stockholder Equity312.2 M297.3 M66.7 M
Slightly volatile
Total Liabilities9.5 M10 M77.4 M
Slightly volatile
Total Current Assets59.1 M101.7 M63.5 M
Slightly volatile
Common Stock1.2 K9001.1 K
Pretty Stable
Other Assets0.80.90.9824
Slightly volatile
Short Term Investments57.3 M93.4 M39.4 M
Slightly volatile
Accounts Payable3.3 M3.4 M2.7 M
Slightly volatile
Capital Lease Obligations878.5 K1.2 M715.7 K
Slightly volatile
Property Plant And Equipment Gross2.9 M3.4 M2.4 M
Slightly volatile
Net Working Capital123.7 M117.8 M28 M
Slightly volatile
Short Term Debt328.2 K616.4 K214.8 K
Slightly volatile

OnKure Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization799.4 K761.3 K213.3 K
Slightly volatile
Other Operating Expenses39.7 M62.5 M28.1 M
Slightly volatile
Research Development32.1 M50.4 M22.8 M
Slightly volatile
Cost Of Revenue404.4 K761.3 K198.5 K
Slightly volatile
Total Operating Expenses39.7 M62.5 M28.1 M
Slightly volatile
Total Other Income Expense Net2.1 MM507.8 K
Slightly volatile
Net Interest Income1.3 MM583.8 K
Slightly volatile
Interest Income1.4 M2.3 M628.2 K
Slightly volatile
Selling General Administrative7.1 M12.2 MM
Slightly volatile
Reconciled Depreciation590 K761.3 K447.3 K
Slightly volatile

OnKure Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow20.1 M26.9 M20.5 M
Slightly volatile
Depreciation799.4 K761.3 K213.3 K
Slightly volatile
Other Non Cash Items270.2 K284.4 K599.9 K
Pretty Stable
Capital Expenditures56.8 K59.8 K118.3 K
Slightly volatile
Total Cash From Financing Activities82.6 M133.5 M62.6 M
Slightly volatile
End Period Cash Flow72.7 M127.4 M62.7 M
Slightly volatile
Stock Based Compensation5.5 M5.2 M943.1 K
Slightly volatile
Other Cashflows From Financing Activities47.8 M58.9 M32.4 M
Slightly volatile
Issuance Of Capital Stock51.6 M67.7 M34.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.08580.09030.8658
Very volatile
Cash Per Share9.079.5520.3486
Pretty Stable
Income Quality0.760.870.9366
Slightly volatile
Current Ratio12.0212.3411.7134
Pretty Stable
Capex Per Share0.00430.00450.0194
Pretty Stable
Interest Debt Per Share0.110.1223.8849
Slightly volatile
Debt To Assets0.01030.01091.0941
Slightly volatile
Ebt Per Ebit1.081.111.0033
Slightly volatile
Long Term Debt To Capitalization1.461.651.7996
Slightly volatile
Quick Ratio12.0212.3411.7134
Pretty Stable
Cash Ratio10.6712.111.0787
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.810.90.987
Slightly volatile
Debt Ratio0.01030.01091.0941
Slightly volatile

OnKure Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap237.2 M131.9 M279.2 M
Slightly volatile
Enterprise Value5.5 M5.8 M241.6 M
Slightly volatile

OnKure Fundamental Market Drivers

About OnKure Therapeutics Financial Statements

OnKure Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although OnKure Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in OnKure Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on OnKure Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue761.3 K404.4 K

Pair Trading with OnKure Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against OnKure Stock

  0.39DSGN Design TherapeuticsPairCorr
The ability to find closely correlated positions to OnKure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics to buy it.
The correlation of OnKure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for OnKure Stock Analysis

When running OnKure Therapeutics' price analysis, check to measure OnKure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics is operating at the current time. Most of OnKure Therapeutics' value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics' price. Additionally, you may evaluate how the addition of OnKure Therapeutics to your portfolios can decrease your overall portfolio volatility.